Invivyd gets Nasdaq notice after shares trade below $1 minimum bid pricePUBT·Jul 24 at 03:05 PMIVVD+7.11%
The Physical Layer of the 2026 Economy is Undergoing a Quiet RebuildGlobal Report·Jul 21 at 04:12 AMSEI+18.10%TECK+8.72%
U.S. stock market midday update: FDA terminates PEMGARDA authorization, Invivyd drops 9.13%Price Alert·Jul 8 at 01:37 PMIVVD+7.11%
Healthcare Stocks Decline as Investors Rotate Away from Safety — Healthcare RoundupMorningStar·Jul 6 at 04:07 PMCLVT-6.51%IVVD+7.11%
Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA | IVVD Stock NewsStockTitan·Jul 5 at 10:01 PMIVVD+7.11%
Invivyd grants 493,000 stock options to 14 new hires at $0.85 per sharePUBT·Jul 2 at 06:01 AMIVVD+7.11%
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | IVVD Stock NewsStockTitan·Jul 1 at 10:01 PMIVVD+7.11%
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine | IVVD Stock NewsStockTitan·Jun 15 at 10:01 PMIVVD+7.11%
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration | IVVD Stock NewsStockTitan·Jun 8 at 10:01 PMIVVD+7.11%
